ARCHIVES

USC Opts for Its own IL-2 Protocol, Shuns NCI Trial

This article is from The Cancer Letter archive.

Vol. 13 No. 19 | May 8, 1987

Download PDF Visit The Full Archive

Related Articles

Tivozanib Trumps Sorafenib In 1st-Line Renal Cancer Study

May 25, 2012

Gore Proposes New War On cancer, Double research Funding Over 5 years

July 9, 1999

ASCO: Anastrozole Adds Treatment Option, But Tamoxifen Remains Standard

September 13, 2002

Meta-Analysis Finds ESA Use In Oncology Associated With Increases In VTE, Mortality.

February 29, 2008

Conte To Introduce Bill To Stem Loss Of NIH “Superstars”

March 31, 1989

Comprehensive Centers Balk At “Requiring” All Control Programs To Be Funneled Through Them

December 5, 1975